Dr Karyn Maclennan
| Position | Research Fellow |
|---|---|
| Research summary | Safe and optimal use of medicines, medicines communication, Māori health, health equity |
Research
Karyn has a background in pharmacology and psychology, has worked broadly across pharmaceutical medicine in New Zealand and the UK and is a member of the Pharmacoepidemiology Research Network Core Academic Group.
She has a strong interest in public outreach and communication about medicines, Māori health, health inequities, and partnering with community groups to collaborate on locally relevant research projects. Her current research includes:
- Interactive public outreach about the science of medicines, which aims to empower children and their whānau to have confident discussions and make informed, shared, and positive decisions about medicines
- A participatory science project with Cystic Fibrosis Otago investigating safe disposal of antibiotic residue in nebulisers
- Exploring the supportive care needs of Māori cancer survivors
- Exploring whānau acceptability of CovidCard contact tracing technology in the Ngongotahā CovidCard trial
Publications
Chambers, T., Egan, R., Maclennan, K., Emery, T., & Derrett, S. (2022). Expert insights on digital contact tracing: interviews with contact tracing policy professionals in New Zealand. Health Promotion International. doi: 10.1093/heapro/daac059
Parkin, L., Maclennan, K., Te Morenga, L., Inder, M., & Moata'ane, L. (2021). What helps and hinders metformin adherence and persistence: A qualitative study exploring the views of people with type 2 diabetes. New Zealand Medical Journal, 134(1536), 25-40. Retrieved from https://www.nzma.org.nz/journal
Maclennan, K., Brounéus, F., & Parkin, L. (2016). Public knowledge and desire for knowledge about drug safety issues: A survey of the general public in New Zealand. Pharmaceutical Medicine, 30(6), 339-348. doi: 10.1007/s40290-016-0164-4
Brounéus, F., Macleod, G., Maclennan, K., Parkin, L., & Paul, C. (2012). Drug safety awareness in New Zealand: Public knowledge and preferred sources for information. Journal of Primary Health Care, 4(4), 288-293.
Maclennan, K. M., Zheng, Y., Sheard, P. W., Williams, S. M., Darlington, C. L., & Smith, P. F. (2003). Adrenalectomy-induced cell death in the dentate gyrus: Further characterisation using TUNEL and effects of the Ginkgo biloba extract, EGb 761 and ginkgolide B. Hippocampus, 13, 212-225.
Darlington, C. L., Smith, P. F., & Maclennan, K. M. (1999). The neuroprotective properties of ginkgo extracts. In T. A. Van Beek (Ed.), Medicinal and Aromatic Plants - Industrial Profiles: Ginkgo Biloba. (pp. 331-344). Amsterdam: Harwood Academic Publishers.
Chapter in Book - Research
Darlington, C. L., Smith, P. F., & Maclennan, K. M. (1997). Effects of Ginkgo biloba extract (EGb 761) on recovery from peripheral vestibular deafferentation (vestibular compensation). In V. Papadopoulos, K. Drieu & Y. Christen (Eds.), Advances in Ginkgo biloba Research, Vol. 6. (pp. 47-58). Paris: Elsevier.
Chapter in Book - Research
Chambers, T., Egan, R., Maclennan, K., Emery, T., & Derrett, S. (2022). Expert insights on digital contact tracing: interviews with contact tracing policy professionals in New Zealand. Health Promotion International. doi: 10.1093/heapro/daac059
Journal - Research Article
Parkin, L., Maclennan, K., Te Morenga, L., Inder, M., & Moata'ane, L. (2021). What helps and hinders metformin adherence and persistence: A qualitative study exploring the views of people with type 2 diabetes. New Zealand Medical Journal, 134(1536), 25-40. Retrieved from https://www.nzma.org.nz/journal
Journal - Research Article
Maclennan, K., Brounéus, F., & Parkin, L. (2016). Public knowledge and desire for knowledge about drug safety issues: A survey of the general public in New Zealand. Pharmaceutical Medicine, 30(6), 339-348. doi: 10.1007/s40290-016-0164-4
Journal - Research Article
Brounéus, F., Macleod, G., Maclennan, K., Parkin, L., & Paul, C. (2012). Drug safety awareness in New Zealand: Public knowledge and preferred sources for information. Journal of Primary Health Care, 4(4), 288-293.
Journal - Research Article
Maclennan, K. M., Zheng, Y., Sheard, P. W., Williams, S. M., Darlington, C. L., & Smith, P. F. (2003). Adrenalectomy-induced cell death in the dentate gyrus: Further characterisation using TUNEL and effects of the Ginkgo biloba extract, EGb 761 and ginkgolide B. Hippocampus, 13, 212-225.
Journal - Research Article
Maclennan, K. M., Darlington, C. L., & Smith, P. F. (2002). The CNS effects of Ginkgo biloba extracts and ginkgolide B. Progress in Neurobiology, 67, 235-257.
Journal - Research Article
Smith, P. F., & Maclennan, K. M. (1999). The neuroprotective effects of platelet activating factor (PAF) receptor antagonists in CNS disorders. Current Opinion in Anti-inflammatory & Immunomodulatory Investigational Drugs, 1, 205-218.
Journal - Research Article
Paul, C. A., Sansom, A. J., Maclennan, K., Darlington, C. L., & Smith, P. F. (1998). The effects of steroids on vestibular compensation and vestibular nucleus neuronal activity in guinea pig. Journal of Vestibular Research, 8(3), 201-207.
Journal - Research Article
Maclennan, K. M., Smith, P. F., & Darlington, C. L. (1996). Platelet-activating factor in the CNS. Progress in Neurobiology, 50(5-6), 585-596.
Journal - Research Article
Maclennan, K., Smith, P. F., & Darlington, C. L. M. (1996). The effects of ginkgolide B (BN52021) on guinea pig vestibular nucleus neurons in vitro: importance of controlling for effects of dimethylsulphoxide (DMSO) vehicles. Neuroscience Research, 26(4), 395-399.
Journal - Research Article
Smith, P. F., Darlington, C. L., & Maclennan, K. (1995). Ginko Biloba: An ancient Chinese tree with neuroprotective properties. Asia Pacific Journal of Pharmacology, 10, 3-4.
Journal - Research Article
Maclennan, K., Smith, P. F., & Darlington, C. L. (1998). Adrenalectomy-induced neuronal degeneration. Progress in Neurobiology, 54, 481-498. doi: 10.1016/S0301-0082(97)00076-2
Journal - Research Other
